Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study von Rustin, G. J. S., Nelstrop, A. E., Tuxen, M. K., Lambert, H. E.

Volltext

Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer von Meyer, T., Nelstrop, A. E., Mahmoudi, M., Rustin, G. J.S.

Volltext

Use of tumour markers in monitoring the course of ovarian cancer von RUSTIN, G. J. S, NELSTROP, A. E, BENTZEN, S. M, PICCART, M. J, BERTELSEN, K

Volltext

Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population von Lambert, H.E., Gregory, W.M., Nelstrop, A.E., Rustin, G.J.S.

Volltext

Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy von Lee, C.K, Pires de Miranda, M, Ledermann, J.A, Ruiz de Elvira, M.-C, Nelstrop, A.E, Lambert, H.E, Rustin, G.J.S, Trask, C.W.L

Volltext

Response and early progression according to CA 125 to assess activity of topotecan vs paclitaxel in relapsed ovarian carcinoma von Rustin, G.J.S, Nelstrop, A.E., Bolis, G., Gore, M., tenBokkel-Huinink, W., Spaczynski, M.

Volltext

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma von Lambert, H. E., Rustin, G. J. S., Gregory, W. M., Nelstrop, A. E.

Volltext